Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023	[1]		12,698,000
Beginning balance at Dec. 31, 2023	[1]	$ 654,952	$ 1		$ 1,657,157	$ (94)	$ (1,002,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			62,000
Issuance of common stock upon exercise of stock options		155			155
Issuance of common stock under employee stock purchase plan (in shares)			24,000
Issuance of common stock under employee stock purchase plan		810			810
Issuance of common stock in connection with restricted stock units, net of tax (in shares)			44,000
Issuance of common stock in connection with restricted stock units, net of tax		(76)			(76)
Stock-based compensation		25,061			25,061
Other comprehensive (loss) income		854				854
Net loss		(151,059)					(151,059)
Ending balance (in shares) at Sep. 30, 2024			12,828,000
Ending balance at Sep. 30, 2024		530,697	$ 1		1,683,107	760	(1,153,171)
Beginning balance (in shares) at Jun. 30, 2024	[1]		12,797,000
Beginning balance at Jun. 30, 2024	[1]	566,501	$ 1		1,675,485	(397)	(1,108,588)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with restricted stock units, net of tax (in shares)			31,000
Stock-based compensation		7,622			7,622
Other comprehensive (loss) income		1,157				1,157
Net loss		(44,583)					(44,583)
Ending balance (in shares) at Sep. 30, 2024			12,828,000
Ending balance at Sep. 30, 2024		$ 530,697	$ 1		1,683,107	760	(1,153,171)
Beginning balance (in shares) at Dec. 31, 2024		14,743,777	14,744,000	[2]
Beginning balance at Dec. 31, 2024	[2]	$ 382,824	$ 1		1,727,638	291	(1,345,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)			26,000
Issuance of common stock under employee stock purchase plan		183			183
Issuance of common stock in connection with restricted stock units, net of tax (in shares)			145,000
Issuance of common stock in connection with restricted stock units, net of tax		1			1
Issuance of common stock in connection with continent consideration milestone (in shares)			625,000
Issuance of common stock in connection with continent consideration milestone		5,894			5,894
Issuance of common stock in connection with PIPE financing (in shares)			3,754,000
Issuance of common stock in connection with PIPE financing		57,774	$ 1		57,773
Stock-based compensation		16,260			16,260
Other comprehensive (loss) income		(90)				(90)
Net loss		$ (133,725)					(133,725)
Ending balance (in shares) at Sep. 30, 2025		19,293,951	19,294,000
Ending balance at Sep. 30, 2025		$ 329,121	$ 2		1,807,749	201	(1,478,831)
Beginning balance (in shares) at Jun. 30, 2025			14,831,000
Beginning balance at Jun. 30, 2025		298,923	$ 1		1,738,850	57	(1,439,985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with restricted stock units, net of tax (in shares)			84,000
Issuance of common stock in connection with continent consideration milestone (in shares)			625,000
Issuance of common stock in connection with continent consideration milestone		5,894			5,894
Issuance of common stock in connection with PIPE financing (in shares)			3,754,000
Issuance of common stock in connection with PIPE financing		57,774	$ 1		57,773
Stock-based compensation		5,232			5,232
Other comprehensive (loss) income		144				144
Net loss		$ (38,846)					(38,846)
Ending balance (in shares) at Sep. 30, 2025		19,293,951	19,294,000
Ending balance at Sep. 30, 2025		$ 329,121	$ 2		$ 1,807,749	$ 201	$ (1,478,831)

[1] Amounts previously reported for common stock and additional paid-in-capital have been retroactively adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2.

[2] Amounts previously reported for common stock and additional paid-in-capital have been adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2.